190 related articles for article (PubMed ID: 16959039)
1. Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT).
Combs SE; Thilmann C; Debus J; Schulz-Ertner D
BMC Cancer; 2006 Sep; 6():222. PubMed ID: 16959039
[TBL] [Abstract][Full Text] [Related]
2. Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: a multicentric study.
Weber DC; Zilli T; Do HP; Nouet P; Gumy Pause F; Pica A
J Neurooncol; 2011 Apr; 102(2):295-300. PubMed ID: 20725849
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy.
Murai T; Sato K; Iwabuchi M; Manabe Y; Ogino H; Iwata H; Tatewaki K; Yokota N; Ohta S; Shibamoto Y
Jpn J Radiol; 2016 Mar; 34(3):211-8. PubMed ID: 26682738
[TBL] [Abstract][Full Text] [Related]
4. Influence of radiotherapy treatment concept on the outcome of patients with localized ependymomas.
Combs SE; Kelter V; Welzel T; Behnisch W; Kulozik AE; Bischof M; Hof H; Debus J; Schulz-Ertner D
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):972-8. PubMed ID: 18337022
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.
Verma J; McCutcheon IE; Waguespack SG; Mahajan A
Pituitary; 2014 Dec; 17(6):539-45. PubMed ID: 24272035
[TBL] [Abstract][Full Text] [Related]
6. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.
Combs SE; Bischof M; Welzel T; Hof H; Oertel S; Debus J; Schulz-Ertner D
J Neurooncol; 2008 Sep; 89(2):205-10. PubMed ID: 18461281
[TBL] [Abstract][Full Text] [Related]
7. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
[TBL] [Abstract][Full Text] [Related]
8. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
Shi W; Blomain ES; Siglin J; Palmer JD; Dan T; Wang Y; Werner-Wasik M; Glass J; Kim L; Bar Ad V; Bhamidipati D; Evans JJ; Judy K; Farrell CJ; Andrews DW
J Neurooncol; 2018 Mar; 137(1):171-177. PubMed ID: 29235052
[TBL] [Abstract][Full Text] [Related]
9. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
[TBL] [Abstract][Full Text] [Related]
10. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated?
Paulino AC
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):757-61. PubMed ID: 11172959
[TBL] [Abstract][Full Text] [Related]
11. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
[TBL] [Abstract][Full Text] [Related]
12. Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy.
Liu F; Xiao JP; Xu YJ; Zhang Y; Xu GZ; Gao L; Yi JL; Luo JW; Huang XD; Huan FK; Fang H; Wan B; Li YX
Chin Med J (Engl); 2012 Jul; 125(14):2525-9. PubMed ID: 22882934
[TBL] [Abstract][Full Text] [Related]
13. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
Tsang DS; Murray L; Ramaswamy V; Zapotocky M; Tabori U; Bartels U; Huang A; Dirks PB; Taylor MD; Hawkins C; Bouffet E; Laperriere N
Neuro Oncol; 2019 Mar; 21(4):547-557. PubMed ID: 30452715
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for intracranial and spinal ependymomas. A retrospective analysis.
Schüller P; Schäfer U; Micke O; Willich N
Strahlenther Onkol; 1999 Mar; 175(3):105-11. PubMed ID: 10093612
[TBL] [Abstract][Full Text] [Related]
15. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
Combs SE; Ahmadi R; Schulz-Ertner D; Thilmann C; Debus J
J Neurooncol; 2005 Feb; 71(3):319-23. PubMed ID: 15735924
[TBL] [Abstract][Full Text] [Related]
16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
17. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
[TBL] [Abstract][Full Text] [Related]
18. Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects.
Harrabi SB; Adeberg S; Welzel T; Rieken S; Habermehl D; Debus J; Combs SE
Radiat Oncol; 2014 Sep; 9():203. PubMed ID: 25227427
[TBL] [Abstract][Full Text] [Related]
19. Is fractionated robotic stereotactic body radiosurgery optional salvage treatment for the re-irradiation of locally recurrent nasopharyngeal carcinoma?
Dogan OY; Yaprak G; Ozyurt H; Bicakci BC; Demircioglu F; Algul E; Isik N
J Cancer Res Ther; 2022; 18(1):66-71. PubMed ID: 35381763
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
Maranzano E; Anselmo P; Casale M; Trippa F; Carletti S; Principi M; Loreti F; Italiani M; Caserta C; Giorgi C
Tumori; 2011; 97(1):56-61. PubMed ID: 21528665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
